Biotech

All Articles

Novartis stirs up new stage of Voyager treaty with $15M capsid deal

.Novartis levels a brand-new outpost in its own collaboration with Voyager Rehabs, paying for $15 th...

Lilly blog posts even more good information on its own once a week insulin possibility

.On the heels of an FDA rejection for its primary rivalrous Novo Nordisk, Eli Lilly is picking up sp...

IN 8bio halts period 2 test, gives up one-half of labor force

.Just a few months after dosing the 1st individual in a phase 2 trial for newly diagnosed glioblasto...

Lilly, Haya ink $1B biobuck being overweight deal to look darker genome

.Eli Lilly's look for obesity intendeds has led it to the black genome. The Big Pharma has actually ...

ArsenalBio raises $325M, rotates out of former lead resource

.Toolbox Biosciences is moving on up. The tissue therapy provider has added on $325 million in ammun...

Lilly- supported effective weight loss biotech files IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually s...

Aelis' marijuana use drug fails phase 2b, steering Indivior to reconsider $100M alternative

.Aelis Farma's hopes of safeguarding a simple, beneficial selection on a $one hundred million possib...

ProKidney halts period 3 test certainly not needed to have for tissue treatment approval

.ProKidney has actually stopped some of a pair of period 3 trials for its own tissue therapy for kid...

Vaxcyte rises on 'sensational' 31-valent PCV succeed against Pfizer

.Vaxcyte unveiled what professionals named "impressive" stage 1/2 data for its 31-valent pneumococca...

Recursion's human brain illness test reveals scant documentation of efficiency

.Recursion has discovered by means of an early test of its tech-enabled strategy to drug revelation,...